at Bayern Munich by Douglas Costa and Kingsley
Coman, says Mario Gomez.
Mario Gomez considers the potential of Douglas Costa and
Kinglsey Coman to be more exciting for Bayern Munich fans
than the talents of Franck Ribery and Arjen Robben.
Ribery and Robben have frequently struggled with injuries – the
former is yet to make an appearance in this Bundesliga
campaign, while the Dutchman has been involved in just six of
their 12 outings so far.
As a result, former Bayern striker Gomez believes supporters
have developed greater enthusiasm about seeing Costa and
Coman develop into integral players.
It is something he sees as natural progression, likening the
situation to the success achieved by Germany after Michael
Ballack's retirement.
"At the European Championships, it will mainly be the [Germany]
World Cup squad – endless experience. After Ballack had gone,
it still went well," Gomez told Kicker.
"In Bayern everyone is talking about Costa and Coman – less
about Ribery and Robben.
"I agree [it is unfair]. But this is top-level sport and players are
interchangeable."
The 30-year-old departed Bayern for Fiorentina in 2013, but
admitted that things did not work out as planned in Italy.
Gomez is now on loan at Turkish side Besiktas, turning down an
offer from England to be somewhere he feels needed and can
compete for further honours.
"Leaving Bayern was a conscious choice – I had wonderful
offers," he added.
"When I saw the Champions League final 2014 – Real [Madrid]
versus Atletico [Madrid] – I thought I might have made the
wrong choice, but that would be unfair to Fiorentina.
"At Fiorentina a lot of things went in the wrong direction, that's
why I am now with Besiktas. [Fiorentina coach] Paulo Sousa
wanted to keep me, but I had to change something.
"In the summer, I had a good option in England, but I wanted to
go to a club where I am needed 100 per cent and can be
successful.
"I want further titles. At Besiktas I feel we can win anything –
like at Bayern. I missed this mentality in Fiorentina, it pushes
me."
No comments:
Post a Comment